Page last updated: 2024-09-04

moxifloxacin and Atypical Mycobacterial Infection, Disseminated

moxifloxacin has been researched along with Atypical Mycobacterial Infection, Disseminated in 40 studies

Research

Studies (40)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	10 (25.00)	29.6817
2010's	17 (42.50)	24.3611
2020's	13 (32.50)	2.80

Authors

Authors	Studies
Chauffour, A; Jarlier, V; Ji, B; Lefrançois, S; Robert, J	1
Akrami, S; Dokht Khosravi, A; Hashemzadeh, M	1
Daneshfar, S; Hashemzadeh, M; Khosravi, AD	1
Du, Y; Huang, H; Huang, J; Jia, J; Nong, Y; Song, W; Tan, Q; Xiao, X; Xu, J; Zhong, R; Zhu, R	1
Alcaide, F; Andres, S; Aubry, A; Benmansour, H; Boarbi, S; Cambau, E; Chryssanthou, E; Cirillo, DM; Fernström, L; Fitzgibbon, MM; Fröberg, G; Giske, CG; Hyyryläinen, HL; Kahlmeter, G; Keller, PM; Machado, D; Maurer, FP; Mengshoel, AT; Mok, S; Nadarajan, D; Schön, T; Svensson, E; Turnidge, J; van Ingen, J; Viveiros, M; Werngren, J	1
Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA	1
Chen, X; Fu, L; Lu, Y; Qi, X; Wang, B; Wang, H; Zhang, W; Zheng, L	1
He, J; Hu, P; Li, N; Men, H; Wang, H; Wang, P; Xiang, J; Yu, X; Zhang, L; Zhang, S; Zheng, H; Zhou, F	1
Cai, BY; Chu, NH; Du, YD; Gao, S; Ge, QP; Guo, R; Han, XQ; Huang, XR; Jing, W; Nie, LH; Nie, WJ; Shang, YY; Shi, WH; Teng, TL; Wang, J; Wang, QF; Xie, ZY; Zhou, WQ	1
Shi, J; Si, X	1
Chonan, M; Fujimoto, Y; Ihara, H; Iwai, M; Kurokawa, K; Misawa, S; Nakamura, A; Ochi, Y; Ohsaka, A; Okabe, T; Shibayama, K; Sumiyoshi, I; Takahashi, K; Takei, S; Togo, S; Watanabe, J	1
Khandelwal, S; Malhotra, B; Sharma, M	1
Brown Elliott, BA; Wallace, RJ	1
Ajitkumar, P; Jakkala, K; Pradhan, A; Swaminath, S	1
Jo, KW; Nam, GB; Shim, TS; Yoon, HY	1
Chang, CH; Chang, YY; Lu, PH	1
Lu, J; Pang, Y; Song, Y; Zhang, Z	1
Aguilar-Ayala, DA; Cnockaert, M; Gonzalez-Y-Merchand, J; Martin, A; Palomino, JC; Vandamme, P	1
Hu, Y; Jiang, W; Jiang, Y; Li, J; Ruan, Q; Wang, X; Xu, Y; Yu, S; Zhang, W; Zhang, Y; Zhou, X	1
Chen, WL; Chu, HS; Hu, FR; Liu, HY; Wang, IJ	1
Andersen, ÅB; Gynthersen, R; Katzenstein, TL; Qvist, T	1
Ali, T; Callahan, C	1
Khatami, A; Sparks, R	1
Gumbo, T; Leff, R; Meek, C; Pasipanodya, J; Sherman, CM; Srivastava, S	1
Olesen, JS; Wang, M; Wejse, C	1
Maley, M; Preda, VA; Sullivan, JR	1
Cremades, R; Garcia-Pachon, E; Rodríguez, JC; Royo, G; Ruiz, M; Santos, A	1
Pacheco, PA; Tam, PM	1
Huang, FC; Shih, MH	1
Daza, RM; Lucena, JL; Ramos, A; Roustan, G	1
Girgis, DO; Karp, CL; Miller, D	1
Andersen, AB; Iversen, M; Katzenstein, TL; Lillebaek, T; Mared, L; Qvist, T	1
López, M; Rodriguez Díaz, JC; Royo, G; Ruiz, M	1
Lee, SB; Mohan, SK; Oliver, KM; Slomovic, AR; Strube, YN	1
Caballero, AR; Dajcs, JJ; Johnston, KH; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA	1
Chauffour, A; Jarlier, V; Ji, B; Lefrançois, S; Robert, J; Truffot, C	1
Mamalis, N	1
Espandar, L; Meyer, JJ; Moshirfar, M	1
Chauffour, A; Jarlier, V; Ji, B; Robert, J	1
Everett, D; Gillespie, SH; Morrissey, I	1

Reviews

1 review(s) available for moxifloxacin and Atypical Mycobacterial Infection, Disseminated

Article	Year
Bilateral Non-tuberculous Mycobacterial Keratitis After Small Incision Lenticule Extraction. Journal of refractive surgery (Thorofare, N.J. : 1995), 2018, Sep-01, Volume: 34, Issue:9 Topics: Administration, Ophthalmic; Administration, Oral; Amikacin; Anti-Bacterial Agents; Clarithromycin; Corneal Surgery, Laser; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Microsurgery; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Myopia; Refraction, Ocular; Surgical Flaps; Tomography, Optical Coherence; Visual Acuity; Young Adult	2018

Article

Year

Bilateral Non-tuberculous Mycobacterial Keratitis After Small Incision Lenticule Extraction.

Journal of refractive surgery (Thorofare, N.J. : 1995), 2018, Sep-01, Volume: 34, Issue:9

Topics: Administration, Ophthalmic; Administration, Oral; Amikacin; Anti-Bacterial Agents; Clarithromycin; Corneal Surgery, Laser; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Microsurgery; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Myopia; Refraction, Ocular; Surgical Flaps; Tomography, Optical Coherence; Visual Acuity; Young Adult

2018

Other Studies

39 other study(ies) available for moxifloxacin and Atypical Mycobacterial Infection, Disseminated

Article	Year
Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10 Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Aza Compounds; Clarithromycin; Colony Count, Microbial; Drug Combinations; Female; Fluoroquinolones; Foot; Mice; Mice, Inbred BALB C; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Quinolines; Rifampin; Streptomycin	2007
Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study. Pathogens and global health, 2023, Volume: 117, Issue:1 Topics: Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Tuberculosis	2023
Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran. PloS one, 2022, Volume: 17, Issue:8 Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Humans; Iran; Laboratories; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Tuberculosis	2022
A case of ascetic fluid Mycobacterium aubagnense infection in a patient with severe peritoneal effusion. BMC infectious diseases, 2023, Feb-07, Volume: 23, Issue:1 Topics: Ascites; Ascitic Fluid; Diuretics; Ethambutol; Humans; Isoniazid; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria	2023
Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium abscessus; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria	2023
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria]. Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin	2023
Efficacy of PBTZ169 and pretomanid against Mycobacterium avium, Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Animals; Anti-Bacterial Agents; Clofazimine; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium abscessus; Mycobacterium avium; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifabutin	2023
Phenotypic and molecular characterisation of a novel species, Epidemiology and infection, 2020, 02-14, Volume: 148 Topics: Aged, 80 and over; Antitubercular Agents; Bacterial Proteins; Base Composition; Chaperonin 60; China; Cluster Analysis; Cytosol; DNA-Directed RNA Polymerases; DNA, Bacterial; DNA, Ribosomal; DNA, Ribosomal Spacer; Fatty Acids; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Phylogeny; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sputum	2020
Efficacy of Moxifloxacin against Biomedical and environmental sciences : BES, 2020, May-20, Volume: 33, Issue:5 Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Zebrafish	2020
Pulmonary and Skeletal Infection of American journal of respiratory and critical care medicine, 2020, 10-15, Volume: 202, Issue:8 Topics: Adult; Bone and Bones; Cough; Female; Fever; Follow-Up Studies; Humans; Levofloxacin; Lung; Magnetic Resonance Imaging; Moxifloxacin; Multimodal Imaging; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Positron-Emission Tomography; Rare Diseases; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome	2020
The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex. BMC microbiology, 2020, 10-19, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Combinations; Drug Synergism; Female; Humans; Imipenem; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous	2020
Drug susceptibiity testing of nontuberculous mycobacteria by broth microdilution method. Indian journal of medical microbiology, 2021, Volume: 39, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Humans; India; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin	2021
Comparison of Antimicrobial agents and chemotherapy, 2021, 06-17, Volume: 65, Issue:7 Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria	2021
A method for the enrichment, isolation and validation of Mycobacterium smegmatis population surviving in the presence of bactericidal concentrations of rifampicin and moxifloxacin. FEMS microbiology letters, 2021, 07-20, Volume: 368, Issue:14 Topics: Antitubercular Agents; Bacteriological Techniques; Drug Tolerance; Gene Expression Profiling; Humans; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Reproducibility of Results; Rifampin	2021
Clinical significance of QT-prolonging drug use in patients with MDR-TB or NTM disease. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2017, 09-01, Volume: 21, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Azithromycin; Child; Clarithromycin; Clofazimine; Diarylquinolines; Female; Fluoroquinolones; Follow-Up Studies; Humans; Lost to Follow-Up; Macrolides; Male; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nitroimidazoles; Nontuberculous Mycobacteria; Oxazoles; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult	2017
Non-Tuberculous Mycobacteria Infection Following Autologous Fat Grafting on the Face. Aesthetic surgery journal, 2017, Dec-13, Volume: 38, Issue:1 Topics: Adipose Tissue; Adult; Anti-Bacterial Agents; Clarithromycin; Cosmetic Techniques; Diagnosis, Differential; Face; Female; Fluoroquinolones; Humans; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Tissue and Organ Harvesting; Transplantation, Autologous	2017
In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex. Diagnostic microbiology and infectious disease, 2018, Volume: 90, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; DNA-Directed RNA Polymerases; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline	2018
Antimicrobial activity against Mycobacterium tuberculosis under in vitro lipid-rich dormancy conditions. Journal of medical microbiology, 2018, Volume: 67, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Drug Tolerance; Fluoroquinolones; Genetic Fitness; Genotype; Humans; Lipid Metabolism; Lipids; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nitroimidazoles; Rifampin	2018
Isolation of Mycobacterium arupense from pleural effusion: culprit or not? BMC infectious diseases, 2018, 05-15, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; Capreomycin; Dexamethasone; Humans; Laryngitis; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pleural Effusion; RNA, Ribosomal, 16S; Tomography, X-Ray Computed	2018
Mycobacterium brisbanense lung infection facilitated by steroid induced adrenal insufficiency. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2019, Volume: 127, Issue:2 Topics: Adrenal Insufficiency; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Male; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections; Sputum	2019
Molteno implant functioning as a culture plate. JAMA ophthalmology, 2013, Volume: 131, Issue:6 Topics: Administration, Ophthalmic; Adult; Anti-Bacterial Agents; Aza Compounds; Device Removal; Eye Infections, Bacterial; Fluoroquinolones; Glaucoma; Humans; Male; Molteno Implants; Moxifloxacin; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Prosthesis-Related Infections; Quinolines; Reoperation; Treatment Outcome	2013
Mycobacterium fortuitum Complex Skin Infection in a Healthy Adolescent. Infectious disorders drug targets, 2014, Volume: 14, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Australia; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial; Trimethoprim, Sulfamethoxazole Drug Combination	2014
Rapid drug tolerance and dramatic sterilizing effect of moxifloxacin monotherapy in a novel hollow-fiber model of intracellular Mycobacterium kansasii disease. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:4 Topics: Anti-Bacterial Agents; Area Under Curve; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluoroquinolones; Lung Diseases; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Reserpine; Sterilization	2015
Mycobacterium chelonae hand infection after steroid injection in a patient with rheumatoid arthritis receiving long-term linezolid therapy. BMJ case reports, 2017, Jan-30, Volume: 2017 Topics: Adrenal Cortex Hormones; Aged; Amputation, Surgical; Anti-Bacterial Agents; Arthritis, Rheumatoid; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Hand; Humans; Injections; Injections, Intra-Articular; Linezolid; Male; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Tenosynovitis	2017
Mycobacterium chelonae infection in a tattoo site. The Medical journal of Australia, 2009, Mar-02, Volume: 190, Issue:5 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Male; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Quinolines; Tattooing	2009
Activity of various drugs alone or in combination against Mycobacterium fortuitum. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2010, Volume: 16, Issue:1 Topics: Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Quinolines	2010
Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis. Journal of cataract and refractive surgery, 2010, Volume: 36, Issue:5 Topics: Administration, Oral; Administration, Topical; Amikacin; Anti-Bacterial Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Quinolines; Young Adult	2010
Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Investigative ophthalmology & visual science, 2011, Jan-05, Volume: 52, Issue:1 Topics: Amikacin; Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Corneal Ulcer; Drug Synergism; Eye Infections, Bacterial; Fluoroquinolones; Methylene Blue; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Photochemotherapy; Quinolines; Rabbits	2011
[Development of subcutaneous nodules after mesotherapy]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:10 Topics: Abscess; Adult; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Cutaneous Fistula; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Mesotherapy; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Quinolines; Skin Diseases, Bacterial; Staining and Labeling; Subcutaneous Tissue	2011
Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management. Clinical & experimental ophthalmology, 2012, Volume: 40, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Aza Compounds; Child; Child, Preschool; Clarithromycin; Combined Modality Therapy; Corneal Ulcer; Eye Infections, Bacterial; Female; Florida; Fluoroquinolones; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ophthalmologic Surgical Procedures; Quinolines; Retrospective Studies; Risk Factors; Surgical Wound Infection; Young Adult	2012
First report of lung transplantation in a patient with active pulmonary Mycobacterium simiae infection. Transplantation proceedings, 2013, Volume: 45, Issue:2 Topics: Anti-Bacterial Agents; Aza Compounds; Bronchiectasis; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Lung Transplantation; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Quinolines; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	2013
In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria. International journal of antimicrobial agents, 2003, Volume: 21, Issue:6 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Oxazolidinones; Quinolines; Spain	2003
Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2005, Volume: 40, Issue:6 Topics: Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Quinolines; Surgical Flaps; Tobramycin	2005
Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo. Current eye research, 2006, Volume: 31, Issue:1 Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ofloxacin; Ophthalmic Solutions; Quinolines; Rabbits	2006
In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Acetamides; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Diarylquinolines; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Foot; In Vitro Techniques; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Nitroimidazoles; Oxazolidinones; Quinolines; Rifampin; Streptomycin; Survival Analysis; Time Factors	2006
The increasing problem of antibiotic resistance. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:11 Topics: Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Drug Resistance, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Quinolines	2007
Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:11 Topics: Adult; Amikacin; Anti-Infective Agents; Aza Compounds; Clarithromycin; Corneal Ulcer; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Quinolines	2007
Bactericidal and sterilizing activities of several orally administered combined regimens against Mycobacterium ulcerans in mice. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Female; Fluoroquinolones; Mice; Mice, Inbred BALB C; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Quinolines; Rifampin; Treatment Outcome	2008
A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model. Journal of medical microbiology, 2001, Volume: 50, Issue:6 Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Quinolines	2001